Steven Cohen’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Sell
129,200
-51,900
-29% -$1.19M ﹤0.01% 2202
2026
Q1
$3.99M Buy
181,100
+111,600
+161% +$1.94M 0.01% 1859
2025
Q4
$819K Buy
+69,500
New +$892K ﹤0.01% 2985
2024
Q4
Sell
-42,900
Closed -$872K 2113
2024
Q3
$872K Hold
42,900
﹤0.01% 1469
2024
Q2
$968K Hold
42,900
﹤0.01% 1284
2024
Q1
$1.13M Hold
42,900
﹤0.01% 1444
2023
Q4
$1.35M Hold
42,900
﹤0.01% 1318
2023
Q3
$1.2M Buy
+42,900
New +$1.47M ﹤0.01% 1273
2019
Q3
Sell
-500,000
Closed -$12M 1161
2019
Q2
$12M Buy
+500,000
New +$14.7M 0.06% 351

Other funds holding CC

Steven Cohen's CC Position: Q2 2026 in Review

Steven Cohen reduced its Chemours (CC) stake by 68% in Q2 2026, selling an estimated $9.48M and leaving 195,149 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Steven Cohen first reported a position in CC in Q3 2016 and has held it in 22 quarters since. The position peaked at $79.6M in Q1 2018. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Steven Cohen held 195,149 shares of Chemours worth $4M as of Q2 2026.
  • Steven Cohen sold 414,122 Chemours shares in Q2 2026, an estimated $9.48M.
  • Chemours made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1914 holding.
  • Steven Cohen first reported a position in Chemours in Q3 2016 and has held it in 22 quarters since.
  • Steven Cohen's Chemours position peaked at $79.6M in Q1 2018.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.